# EVGN — Evogene Ltd · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** EVGN  
**Sources:** 17  
**Published:** 2026-10-26  
**Canonical:** https://app.k3vl4r.com/research/deep-research-evgn-evogene-ltd-catalysts-narrative-risks-9396

---

# Evogene Ltd. (NASDAQ/TASE: EVGN) — Research Notes (as of 2026-10-26)

**Company profile:** Evogene is an Israel-based (Rehovot) computational chemistry/biology company using its ChemPass AI generative-AI engine to design small molecules and crop traits for pharmaceutical and agricultural applications. It is classified under Healthcare / Biotechnology and trades on Nasdaq Capital Market. [[2]](https://stockanalysis.com/stocks/evgn/), [[5]](https://www.marketbeat.com/earnings/reports/2026-11-19-evogene-ltd-stock/), [[12]](https://evogene.com/investor-relations/), [[16]](https://investingcalendar.com/stock/xnas/evgn) Below, I flag where internal sources conflict on a factual point.

## Recent catalysts (last ~1–3 months)

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-evgn-evogene-ltd-catalysts-narrative-risks-9396 (free to sign up)._